Notable Analyst Upgrades and Downgrades for Week of May 30 2022

 

Upgrades:

 

Linde (NYSE:LIN) was upgraded by Evercore ISI to an "outperform" rating in a research report issued to clients and investors on Tuesday, The Fly reports.

LIN has been the topic of a number of other reports. Credit Suisse Group began coverage on shares of Linde in a research report on Tuesday. They set an "outperform" rating and a $380.00 price objective on the stock. BMO Capital Markets lowered their price objective on shares of Linde from $405.00 to $365.00 and set an "outperform" rating on the stock in a research report on Monday, February 14th. Jefferies Financial Group began coverage on shares of Linde in a research report on Wednesday, March 30th. They set a "buy" rating and a $390.00 price objective on the stock. HSBC boosted their target price on shares of Linde from $366.00 to $382.00 and gave the stock a "buy" rating in a research report on Friday, February 18th. Finally, Zacks Investment Research raised shares of Linde from a "sell" rating to a "hold" rating and set a $312.00 target price for the company in a research report on Monday, February 14th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, Linde currently has an average rating of "Buy" and a consensus price target of $367.14. Read more …

 

Magellan Midstream Partners (NYSE:MMP) was upgraded by stock analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating in a research report issued to clients and investors on Tuesday, The Fly reports.

A number of other analysts have also commented on MMP. TD Securities boosted their target price on Magellan Midstream Partners from $51.00 to $52.00 and gave the company a "hold" rating in a research report on Friday, May 6th. Morgan Stanley boosted their target price on Magellan Midstream Partners from $50.00 to $54.00 and gave the company an "underweight" rating in a research report on Tuesday, April 26th. JPMorgan Chase & Co. raised Magellan Midstream Partners from a "neutral" rating to an "overweight" rating and boosted their target price for the company from $52.00 to $57.00 in a research report on Wednesday, May 25th. StockNews.com started coverage on Magellan Midstream Partners in a research report on Thursday, March 31st. They issued a "hold" rating for the company. Finally, Mizuho boosted their target price on Magellan Midstream Partners from $50.00 to $52.00 and gave the company a "neutral" rating in a research report on Wednesday, March 30th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $52.30. Read more …

 

Danaher (NYSE:DHR) was upgraded by investment analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a research note issued to investors on Wednesday, The Fly reports.

A number of other research analysts have also recently commented on the company. William Blair restated an "outperform" rating on shares of Danaher in a research report on Friday, April 22nd. UBS Group decreased their target price on Danaher from $365.00 to $340.00 in a research report on Sunday, April 24th. StockNews.com cut Danaher from a "buy" rating to a "hold" rating in a research report on Friday, April 22nd. Zacks Investment Research cut Danaher from a "buy" rating to a "hold" rating and set a $278.00 target price on the stock. in a research report on Monday, April 25th. Finally, Robert W. Baird decreased their target price on Danaher from $334.00 to $319.00 and set an "outperform" rating on the stock in a research report on Friday, April 22nd. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $331.14. Read more …

 

 

Xylem (NYSE:XYL) was upgraded by investment analysts at Cowen from a "market perform" rating to an "outperform" rating in a research report issued to clients and investors on Wednesday, Briefing.com reports. The firm currently has a $75.00 target price on the industrial products company's stock. Cowen's price objective indicates a potential downside of 10.98% from the stock's current price.

Other analysts have also recently issued reports about the company. Stifel Nicolaus dropped their price objective on Xylem from $100.00 to $90.00 and set a "hold" rating for the company in a report on Monday, April 18th. Raymond James raised Xylem from an "underperform" rating to a "market perform" rating in a report on Tuesday, April 5th. Morgan Stanley dropped their price objective on Xylem from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Monday, April 18th. Zacks Investment Research raised Xylem from a "sell" rating to a "hold" rating and set a $89.00 price target for the company in a research note on Thursday, May 12th. Finally, TheStreet cut Xylem from a "b" rating to a "c+" rating in a research note on Monday, February 7th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Xylem has an average rating of "Hold" and a consensus price target of $108.55. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of January 24 2022 (Part 2)

 

Upgrades:

 

Williams-Sonoma (NYSE:WSM) was upgraded by investment analysts at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating in a report released on Thursday, The Fly reports.

Several other research firms also recently commented on WSM. Loop Capital raised shares of Williams-Sonoma from a “hold” rating to a “buy” rating and set a $205.00 price target on the stock in a research note on Wednesday, December 22nd. Telsey Advisory Group raised their target price on shares of Williams-Sonoma from $220.00 to $250.00 and gave the company an “outperform” rating in a research report on Friday, November 19th. Wedbush cut their target price on shares of Williams-Sonoma from $250.00 to $190.00 in a research report on Wednesday, January 5th. Wells Fargo & Company cut their target price on shares of Williams-Sonoma from $205.00 to $180.00 and set an “equal weight” rating on the stock in a research report on Wednesday, January 5th. Finally, Citigroup cut their target price on shares of Williams-Sonoma from $225.00 to $165.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 18th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, Williams-Sonoma currently has an average rating of “Hold” and a consensus target price of $179.35. Read more …

 

Apple (NASDAQ:AAPL) was upgraded by stock analysts at New Street Research from a "sell" rating to a "neutral" rating in a report released on Friday, Briefing.com reports. The brokerage currently has a $165.00 price target on the iPhone maker's stock. New Street Research's price objective points to a potential upside of 3.63% from the stock's current price.

A number of other equities analysts have also issued reports on the stock. Morgan Stanley raised their price target on shares of Apple from $200.00 to $210.00 and gave the stock an "overweight" rating in a research report on Friday. Raymond James upped their target price on shares of Apple from $185.00 to $190.00 and gave the stock an "outperform" rating in a research note on Friday. Credit Suisse Group initiated coverage on Apple in a report on Friday, October 29th. They issued a "neutral" rating and a $150.00 price objective for the company. Cowen increased their price objective on Apple from $180.00 to $200.00 in a research report on Friday. Finally, Piper Sandler raised their price target on Apple from $175.00 to $200.00 and gave the company an "overweight" rating in a research report on Friday, January 14th. Seven analysts have rated the stock with a hold rating, twenty-four have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $186.59. Read more …

 

Crown Castle International (NYSE:CCI) was upgraded by investment analysts at Raymond James to an "outperform" rating in a research report issued on Friday, Stock Target Advisor reports. The firm currently has a $184.00 price objective on the real estate investment trust's stock. Raymond James' price objective points to a potential upside of 7.24% from the stock's previous close.

Several other equities analysts have also issued reports on the stock. Citigroup lifted their target price on shares of Crown Castle International from $200.00 to $204.00 in a report on Thursday. Morgan Stanley lowered their target price on shares of Crown Castle International from $208.00 to $207.00 and set an "overweight" rating for the company in a report on Wednesday. Wolfe Research initiated coverage on shares of Crown Castle International in a report on Wednesday, October 13th. They set an "underperform" rating and a $162.00 target price for the company. Credit Suisse Group upgraded shares of Crown Castle International from a "neutral" rating to an "outperform" rating and lifted their target price for the company from $192.00 to $195.00 in a report on Tuesday, October 19th. Finally, Jefferies Financial Group lowered shares of Crown Castle International from a "buy" rating to a "hold" rating and lowered their target price for the company from $226.00 to $203.00 in a report on Monday, January 10th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, Crown Castle International has an average rating of "Buy" and an average target price of $201.38. Read more …

 

 

General Dynamics (NYSE:GD) was upgraded by equities research analysts at Wolfe Research to a "peer perform" rating in a research report issued to clients and investors on Friday, Stock Target Advisor reports.

Other equities analysts have also issued reports about the stock. Wells Fargo & Company boosted their price objective on shares of General Dynamics from $230.00 to $235.00 and gave the stock an "overweight" rating in a report on Monday, January 10th. Susquehanna Bancshares boosted their price objective on shares of General Dynamics from $225.00 to $240.00 and gave the stock a "positive" rating in a report on Thursday, October 28th. Susquehanna boosted their price objective on shares of General Dynamics from $225.00 to $240.00 and gave the stock a "positive" rating in a report on Thursday, October 28th. Finally, UBS Group upgraded shares of General Dynamics from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $220.00 to $245.00 in a report on Tuesday, December 14th. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $216.92. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of January 10 2022 (Part 1)

 

Upgrades:

 

CVS Health (NYSE:CVS) was upgraded by stock analysts at Edward Jones from a “hold” rating to a “buy” rating in a note issued to investors on Monday, The Fly reports.

Several other equities research analysts have also recently weighed in on the stock. Seaport Research Partners assumed coverage on shares of CVS Health in a research report on Wednesday, December 1st. They set a “buy” rating and a $110.00 price objective for the company. The Goldman Sachs Group assumed coverage on shares of CVS Health in a report on Tuesday, December 14th. They issued a “buy” rating and a $121.00 target price for the company. Citigroup increased their target price on shares of CVS Health from $98.00 to $111.00 and gave the stock a “buy” rating in a report on Thursday, November 4th. They noted that the move was a valuation call. Seaport Global Securities started coverage on shares of CVS Health in a report on Wednesday, December 1st. They issued a “buy” rating and a $110.00 price objective for the company. Finally, Seaport Res Ptn reiterated a “buy” rating on shares of CVS Health in a report on Wednesday, December 1st. Four investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $111.73. Read more …

 

Kimco Realty (NYSE:KIM) was upgraded by research analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research note issued on Monday, The Fly reports. The firm currently has a $29.00 price objective on the real estate investment trust’s stock, up from their prior price objective of $24.00. Jefferies Financial Group’s price objective would suggest a potential upside of 17.93% from the stock’s current price.

Other equities research analysts also recently issued research reports about the company. Argus raised Kimco Realty from a “hold” rating to a “buy” rating and set a $27.00 target price for the company in a report on Wednesday, January 5th. Truist upped their target price on Kimco Realty from $25.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, December 10th. Wolfe Research began coverage on shares of Kimco Realty in a research note on Thursday, September 23rd. They set a “market perform” rating and a $24.00 target price for the company. BTIG Research reaffirmed a “hold” rating on shares of Kimco Realty in a research note on Sunday, September 26th. Finally, Evercore ISI upgraded Kimco Realty from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $24.00 to $26.00 in a research report on Monday, November 22nd. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $25.81. Read more …

 

Kinder Morgan (NYSE:KMI) was upgraded by equities research analysts at Wolfe Research from an “underperform” rating to a “market perform” rating in a report issued on Monday, The Fly reports. The brokerage currently has a $17.00 target price on the pipeline company’s stock, up from their previous target price of $16.00. Wolfe Research’s target price suggests a potential downside of 2.19% from the stock’s current price.

KMI has been the subject of a number of other reports. Zacks Investment Research cut shares of Kinder Morgan from a “buy” rating to a “hold” rating and set a $19.00 target price for the company. in a report on Wednesday, October 27th. Bank of America started coverage on shares of Kinder Morgan in a report on Tuesday, September 28th. They set a “neutral” rating for the company. Finally, Mizuho reduced their target price on shares of Kinder Morgan from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, December 6th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $17.92. Read more …

 

 

L3Harris Technologies (NYSE:LHX) was upgraded by research analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating in a research note issued to investors on Tuesday, Price Targets.com reports. The brokerage presently has a $266.00 price objective on the stock. Wolfe Research's price target would indicate a potential upside of 19.05% from the company's current price.

A number of other equities research analysts have also recently commented on the company. UBS Group cut L3Harris Technologies from a "buy" rating to a "neutral" rating and dropped their target price for the company from $260.00 to $235.00 in a research report on Tuesday, December 14th. Robert W. Baird raised shares of L3Harris Technologies from a "neutral" rating to an "outperform" rating and set a $248.00 price target on the stock in a research note on Thursday, January 6th. The Goldman Sachs Group lowered shares of L3Harris Technologies from a "neutral" rating to a "sell" rating and set a $207.00 price target on the stock. in a research note on Thursday, September 23rd. Wells Fargo & Company raised shares of L3Harris Technologies from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $243.00 to $254.00 in a research note on Monday. Finally, Morgan Stanley decreased their target price on shares of L3Harris Technologies from $238.00 to $230.00 and set an "equal weight" rating on the stock in a research note on Thursday, November 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and ten have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $243.77. Read more …

Notable Analyst Upgrades and Downgrades for Week of January 3 2022 (Part 2)

 

Upgrades:

 

Kimco Realty (NYSE:KIM) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating in a research report issued on Wednesday, Analyst Ratings Network reports. The brokerage currently has a $27.00 target price on the real estate investment trust's stock. Argus' price objective indicates a potential upside of 7.02% from the stock's previous close.

KIM has been the topic of a number of other research reports. Evercore ISI upgraded Kimco Realty from an "in-line" rating to an "outperform" rating and lifted their target price for the company from $24.00 to $26.00 in a research report on Monday, November 22nd. Wolfe Research initiated coverage on Kimco Realty in a research report on Thursday, September 23rd. They issued a "market perform" rating and a $24.00 target price on the stock. Citigroup lifted their target price on Kimco Realty from $26.00 to $28.00 and gave the company a "buy" rating in a research report on Thursday, December 2nd. Truist lifted their target price on Kimco Realty from $25.00 to $27.00 and gave the company a "buy" rating in a research report on Friday, December 10th. Finally, Deutsche Bank Aktiengesellschaft downgraded Kimco Realty from a "buy" rating to a "hold" rating and boosted their price objective for the company from $24.00 to $26.00 in a report on Monday. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $25.60. Read more …

 

MetLife (NYSE:MET) was upgraded by Evercore ISI from an "in-line" rating to an "outperform" rating in a report issued on Wednesday, Price Targets.com reports. The brokerage presently has a $75.00 price objective on the financial services provider's stock, up from their previous price objective of $67.00. Evercore ISI's price objective suggests a potential upside of 15.49% from the company's current price.

Several other research analysts also recently weighed in on MET. The Goldman Sachs Group assumed coverage on shares of MetLife in a research report on Thursday, December 2nd. They issued a "buy" rating and a $77.00 target price on the stock. Wells Fargo & Company dropped their target price on shares of MetLife from $75.00 to $74.00 and set an "overweight" rating on the stock in a research report on Tuesday. Barclays boosted their price objective on shares of MetLife from $69.00 to $72.00 and gave the company an "overweight" rating in a research report on Tuesday, October 12th. Finally, Morgan Stanley boosted their price objective on shares of MetLife from $74.00 to $75.00 and gave the company an "overweight" rating in a research report on Thursday, October 14th. Thirteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, MetLife has an average rating of "Buy" and an average price target of $69.29. Read more …

 

Pfizer (NYSE:PFE) was upgraded by Bank of America from a "neutral" rating to a "buy" rating in a report released on Wednesday, The Fly reports.

Several other research firms have also weighed in on PFE. Sanford C. Bernstein raised their price objective on shares of Pfizer from $44.00 to $65.00 and gave the company a "market perform" rating in a research report on Monday. UBS Group upgraded shares of Pfizer from a "neutral" rating to a "buy" rating and raised their target price for the stock from $52.00 to $60.00 in a report on Monday, December 13th. Truist raised their target price on shares of Pfizer from $43.00 to $58.00 and gave the stock a "buy" rating in a report on Wednesday, November 24th. JPMorgan Chase & Co. set a $53.00 target price on shares of Pfizer in a report on Monday, December 13th. Finally, Barclays set a $54.00 target price on shares of Pfizer in a report on Tuesday. Nine analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $56.15. Read more …

 

 

Suncor Energy (NYSE:SU) (TSE:SU) was upgraded by equities research analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating in a report released on Wednesday, The Fly reports.

A number of other analysts have also recently commented on SU. Credit Suisse Group upped their price objective on shares of Suncor Energy from C$36.00 to C$42.00 and gave the company an "outperform" rating in a research report on Tuesday, November 2nd. BMO Capital Markets upped their price objective on shares of Suncor Energy from C$39.00 to C$43.00 and gave the company an "outperform" rating in a research report on Friday, October 29th. TD Securities increased their target price on Suncor Energy from C$39.00 to C$40.00 and gave the stock a "buy" rating in a report on Thursday, October 28th. Scotiabank increased their target price on Suncor Energy from C$33.00 to C$37.00 and gave the stock an "outperform" rating in a report on Friday, November 19th. Finally, JPMorgan Chase & Co. upgraded Suncor Energy from a "neutral" rating to an "overweight" rating and increased their target price for the stock from $29.00 to $39.00 in a report on Thursday, October 28th. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $37.86. Read more …

Notable Analyst Upgrades and Downgrades for Week of October 18 2021

 

 

Upgrades:

 

Novo Nordisk A/S (NYSE:NVO) was upgraded by investment analysts at SEB Equities from a “hold” rating to a “buy” rating in a report issued on Monday, The Fly reports.

Other equities analysts have also issued research reports about the company. Berenberg Bank reissued a “hold” rating on shares of Novo Nordisk A/S in a research report on Friday, September 3rd. DNB Markets raised Novo Nordisk A/S from a “hold” rating to a “buy” rating in a research report on Thursday, August 5th. Bank of America upgraded Novo Nordisk A/S from a “neutral” rating to a “buy” rating in a report on Thursday, August 5th. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Novo Nordisk A/S in a report on Friday, August 6th. Finally, Credit Suisse Group restated a “neutral” rating on shares of Novo Nordisk A/S in a research note on Monday, August 23rd. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $91.00. Read more …

 

Occidental Petroleum (NYSE:OXY) was upgraded by equities researchers at Truist Securities from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has a $50.00 price target on the oil and gas producer's stock. Truist Securities' target price indicates a potential upside of 57.93% from the stock's previous close.

A number of other research firms have also recently commented on OXY. Mizuho boosted their target price on shares of Occidental Petroleum from $37.00 to $39.00 and gave the stock a "buy" rating in a research note on Thursday, July 15th. Evercore ISI raised shares of Occidental Petroleum from an "in-line" rating to an "outperform" rating and boosted their target price for the stock from $35.00 to $40.00 in a research note on Wednesday, September 29th. Wells Fargo & Company boosted their target price on shares of Occidental Petroleum from $29.00 to $34.00 and gave the stock an "equal weight" rating in a research note on Thursday. Piper Sandler upped their price objective on shares of Occidental Petroleum from $30.00 to $38.00 and gave the company a "neutral" rating in a research note on Friday, July 23rd. They noted that the move was a valuation call. Finally, Truist raised shares of Occidental Petroleum from a "hold" rating to a "buy" rating and upped their price objective for the company from $35.00 to $50.00 in a research note on Monday. Four equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $31.35. Read more …

 

Public Storage (NYSE:PSA) was upgraded by Wolfe Research from a “peer perform” rating to an “outperform” rating in a research report issued to clients and investors on Monday, The Fly reports.

Other equities research analysts have also recently issued reports about the stock. Citigroup boosted their price target on shares of Public Storage from $296.00 to $325.00 and gave the stock a “neutral” rating in a research report on Thursday, July 1st. Raymond James raised shares of Public Storage from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a research report on Tuesday, August 10th. UBS Group started coverage on shares of Public Storage in a research report on Thursday, June 24th. They set a “neutral” rating and a $310.00 price target on the stock. Truist Securities boosted their price objective on shares of Public Storage from $315.00 to $322.00 and gave the stock a “buy” rating in a research note on Monday, August 16th. Finally, Zacks Investment Research lowered shares of Public Storage from a “buy” rating to a “hold” rating and set a $329.00 price objective on the stock. in a research note on Friday, July 23rd. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $314.50. Read more …

 

 

Albemarle (NYSE:ALB) was upgraded by investment analysts at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating in a research report issued on Tuesday, Price Targets.com reports. The firm presently has a $280.00 price objective on the specialty chemicals company’s stock, up from their previous price objective of $246.00. Royal Bank of Canada’s price objective indicates a potential upside of 18.19% from the company’s current price.

ALB has been the subject of a number of other research reports. Bank of America boosted their price objective on Albemarle from $121.00 to $140.00 and gave the company an “underperform” rating in a research report on Friday, August 6th. They noted that the move was a valuation call. BMO Capital Markets lifted their target price on Albemarle from $265.00 to $290.00 and gave the company an “outperform” rating in a research note on Monday, September 13th. Deutsche Bank Aktiengesellschaft lifted their target price on Albemarle from $245.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, September 13th. KeyCorp lifted their target price on Albemarle from $127.00 to $131.00 and gave the company an “underweight” rating in a research note on Monday, October 11th. Finally, Zacks Investment Research raised Albemarle from a “hold” rating to a “buy” rating and set a $197.00 target price on the stock in a research note on Tuesday, July 13th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, Albemarle presently has an average rating of “Hold” and an average target price of $213.09. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of September 6, 2021

 

Upgrades:

 

Bank of Montreal (NYSE:BMO) (TSE:BMO) was upgraded by analysts at Barclays from an "underweight" rating to an "equal weight" rating in a research note issued to investors on Tuesday, Briefing.com reports.

Other analysts have also issued research reports about the stock. Credit Suisse Group raised their price objective on shares of Bank of Montreal from $138.00 to $144.00 and gave the stock an "outperform" rating in a report on Wednesday, August 25th. CIBC raised their price objective on shares of Bank of Montreal from $139.00 to $148.00 and gave the stock an "outperformer" rating in a report on Wednesday, August 25th. Canaccord Genuity raised their price objective on shares of Bank of Montreal from C$143.00 to C$149.00 and gave the stock a "buy" rating in a report on Wednesday, August 25th. BMO Capital Markets raised their price objective on shares of Bank of Montreal from C$150.00 to C$152.00 and gave the stock a "buy" rating in a report on Wednesday, August 25th. Finally, Desjardins raised their price objective on shares of Bank of Montreal from C$133.00 to C$138.00 and gave the stock a "hold" rating in a report on Thursday, August 26th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $142.27. Read more …

 

The Southern (NYSE:SO) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating in a research note issued on Tuesday, The Fly reports.

Other analysts also recently issued reports about the company. Wells Fargo & Company reaffirmed a "buy" rating on shares of The Southern in a report on Monday, August 2nd. Morgan Stanley boosted their target price on The Southern from $60.00 to $64.00 and gave the company an "underweight" rating in a report on Thursday, August 19th. Barclays boosted their target price on The Southern from $70.00 to $76.00 and gave the company an "overweight" rating in a report on Tuesday, May 25th. Credit Suisse Group reissued a "buy" rating on shares of The Southern in a report on Wednesday, May 19th. Finally, Mizuho boosted their target price on The Southern from $57.00 to $60.00 and gave the company an "underperform" rating in a report on Monday, August 30th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $68.42. Read more …

 

The Toronto-Dominion Bank (NYSE:TD) (TSE:TD) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a note issued to investors on Tuesday, The Fly reports.

TD has been the topic of several other reports. Zacks Investment Research cut The Toronto-Dominion Bank from a “hold” rating to a “sell” rating in a research note on Tuesday. BMO Capital Markets reduced their price objective on The Toronto-Dominion Bank from C$96.00 to C$94.00 and set a “market perform” rating on the stock in a research note on Friday, August 27th. Finally, Scotiabank reduced their price objective on The Toronto-Dominion Bank from C$95.00 to C$94.00 in a research note on Tuesday, August 17th. Four analysts have rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $80.60. Read more …

 

 

Ventas (NYSE:VTR) was upgraded by Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report issued on Tuesday, The Fly reports.

Several other equities analysts also recently commented on the stock. Royal Bank of Canada upped their price target on shares of Ventas from $62.00 to $65.00 and gave the company an "outperform" rating in a report on Wednesday, June 30th. Wolfe Research began coverage on shares of Ventas in a research note on Monday, June 14th. They issued an "outperform" rating and a $71.00 target price on the stock. BMO Capital Markets upgraded shares of Ventas from an "underperform" rating to a "market perform" rating and set a $60.00 target price on the stock in a research note on Thursday, August 26th. Robert W. Baird upgraded shares of Ventas from a "neutral" rating to an "outperform" rating and set a $58.00 target price on the stock in a research note on Thursday, May 13th. Finally, Scotiabank upped their target price on shares of Ventas from $61.00 to $63.00 and gave the stock a "sector perform" rating in a research note on Thursday, July 1st. Eight equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $58.41. Read more …

Notable Analyst Upgrades and Downgrades for Week of January 11, 2021 (Part 2)

 

Upgrades:

 

Intel (NASDAQ:INTC) was upgraded by equities research analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a note issued to investors on Thursday, Briefing.com reports. The brokerage presently has a $70.00 price target on the chip maker’s stock, up from their previous price target of $50.00. BMO Capital Markets’ target price would indicate a potential upside of 22.91% from the stock’s current price.

A number of other equities analysts have also recently issued reports on INTC. Deutsche Bank Aktiengesellschaft cut their target price on shares of Intel from $60.00 to $55.00 and set a “hold” rating on the stock in a report on Friday, October 23rd. The Goldman Sachs Group raised their target price on shares of Intel from $38.00 to $42.00 and gave the stock a “sell” rating in a report on Monday, December 14th. Bank of America cut shares of Intel to a “sell” rating and set a $45.00 target price on the stock. in a report on Tuesday, December 15th. Smith Barney Citigroup cut their target price on shares of Intel from $53.00 to $50.00 in a report on Friday, October 23rd. Finally, Royal Bank of Canada set a $40.00 target price on shares of Intel and gave the stock a “sell” rating in a report on Wednesday. Eleven research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and eighteen have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $59.62. Read more …

 

Chevron (NYSE:CVX) was upgraded by investment analysts at HSBC to a “buy” rating in a report issued on Thursday, TipRanks reports. The brokerage currently has a $105.00 price target on the oil and gas company’s stock. HSBC’s price objective suggests a potential upside of 12.60% from the company’s current price.

Other equities analysts also recently issued research reports about the stock. Wells Fargo & Company downgraded shares of Chevron from an “overweight” rating to an “equal weight” rating and set a $105.00 price target for the company. in a research note on Tuesday, December 15th. MKM Partners began coverage on shares of Chevron in a research note on Thursday, September 24th. They issued a “buy” rating and a $121.00 price objective for the company. Scotia Howard Weill cut shares of Chevron from a “buy” rating to a “sector perform” rating and set a $121.00 target price for the company. in a report on Thursday, September 24th. BidaskClub raised shares of Chevron from a “strong sell” rating to a “sell” rating in a report on Saturday, January 9th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $95.00 price target on shares of Chevron in a report on Tuesday, November 17th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eighteen have issued a buy rating to the company’s stock. Chevron presently has a consensus rating of “Buy” and a consensus target price of $103.00. Read more …

 

Crown Castle International (NYSE:CCI) was upgraded by analysts at Smith Barney Citigroup from a "neutral" rating to a "buy" rating in a report issued on Thursday, The Fly reports.

Several other analysts also recently weighed in on CCI. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell upgraded shares of Crown Castle International from a "neutral" rating to a "buy" rating and set a $170.00 target price for the company in a report on Thursday. Deutsche Bank Aktiengesellschaft raised shares of Crown Castle International from a "hold" rating to a "buy" rating and boosted their price target for the company from $177.00 to $180.00 in a research report on Friday, December 11th. Wells Fargo & Company boosted their price target on shares of Crown Castle International from $170.00 to $175.00 and gave the company an "equal weight" rating in a research report on Wednesday, September 16th. Credit Suisse Group reduced their price target on shares of Crown Castle International from $148.00 to $146.00 and set a "neutral" rating for the company in a research report on Friday, October 23rd. Finally, Raymond James raised shares of Crown Castle International from a "market perform" rating to an "outperform" rating and set a $172.00 price target for the company in a research report on Monday, October 26th. Five equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. Crown Castle International has a consensus rating of "Buy" and an average target price of $174.82. Read more …

 

 

UBS Group (NYSE:UBS) was upgraded by Berenberg Bank from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Briefing.com reports.

A number of other equities analysts have also commented on UBS. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of UBS Group in a research note on Monday, December 7th. Credit Suisse Group restated a “buy” rating on shares of UBS Group in a research note on Wednesday, October 21st. The Goldman Sachs Group downgraded UBS Group from a “buy” rating to a “neutral” rating in a report on Wednesday, November 18th. Morgan Stanley reaffirmed an “equal weight” rating on shares of UBS Group in a report on Tuesday, November 24th. Finally, Bank of America reaffirmed a “buy” rating on shares of UBS Group in a report on Friday, November 27th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $16.00. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of December 7, 2020

 

Upgrades:

 

AstraZeneca (NYSE:AZN) was upgraded by research analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating in a research note issued on Monday, Briefing.com reports.

Several other brokerages also recently commented on AZN. HSBC upgraded shares of AstraZeneca from a "reduce" rating to a "hold" rating in a report on Wednesday, November 11th. Oddo Bhf upgraded AstraZeneca from a "reduce" rating to a "buy" rating in a research note on Wednesday, September 23rd. Berenberg Bank initiated coverage on AstraZeneca in a report on Tuesday, September 29th. They issued a "buy" rating on the stock. Finally, UBS Group upgraded AstraZeneca from a "sell" rating to a "neutral" rating in a report on Monday, November 30th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of "Buy" and an average price target of $61.00.

AZN stock opened at $53.74 on Monday. The company has a 50 day moving average of $53.58 and a two-hundred day moving average of $54.49. The company has a market cap of $141.05 billion, a price-to-earnings ratio of 64.75, a PEG ratio of 1.63 and a beta of 0.50. AstraZeneca has a 12-month low of $36.15 and a 12-month high of $64.94. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 1.14. Read more …

 

Vodafone Group (NASDAQ:VOD) was upgraded by Redburn Partners from a “neutral” rating to a “buy” rating in a research note issued on Monday, The Fly reports.

VOD has been the topic of a number of other research reports. Zacks Investment Research upgraded Vodafone Group from a “hold” rating to a “buy” rating and set a $18.00 price target on the stock in a report on Friday, November 20th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Vodafone Group in a report on Wednesday, October 7th. UBS Group reaffirmed a “buy” rating on shares of Vodafone Group in a research note on Wednesday, November 11th. Finally, BidaskClub lowered Vodafone Group from a “sell” rating to a “strong sell” rating in a research note on Saturday, November 7th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $17.00. Read more …

 

The Unilever Group (NYSE:UN) was upgraded by investment analysts at Investec from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, The Fly reports.

UN has been the topic of a number of other research reports. Zacks Investment Research lowered shares of The Unilever Group from a “buy” rating to a “hold” rating in a report on Friday, November 6th. Credit Suisse Group reissued an “outperform” rating on shares of The Unilever Group in a research note on Monday, August 17th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell initiated coverage on The Unilever Group in a research report on Thursday, November 12th. They issued a “buy” rating for the company. Smith Barney Citigroup assumed coverage on The Unilever Group in a research report on Thursday, November 12th. They set a “buy” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft started coverage on The Unilever Group in a research report on Monday, October 19th. They set a “buy” rating for the company. Four analysts have rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $59.50. Read more …

 

 

Chubb (NYSE:CB) was upgraded by investment analysts at Smith Barney Citigroup from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Tuesday, The Fly reports. The firm presently has a $176.00 price objective on the financial services provider's stock, up from their previous price objective of $138.00. Smith Barney Citigroup's price objective points to a potential upside of 15.04% from the stock's previous close.

Other equities analysts have also recently issued reports about the company. Raymond James upgraded Chubb from an "outperform" rating to a "strong-buy" rating and increased their price target for the stock from $150.00 to $180.00 in a report on Tuesday, November 24th. Bank of America upgraded Chubb from an "underperform" rating to a "neutral" rating and increased their price target for the stock from $123.00 to $132.00 in a report on Thursday, October 29th. They noted that the move was a valuation call. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised Chubb from a "neutral" rating to a "buy" rating and upped their target price for the stock from $138.00 to $176.00 in a research report on Tuesday. Morgan Stanley upped their target price on Chubb from $137.00 to $149.00 and gave the stock an "equal weight" rating in a research report on Tuesday, November 24th. Finally, MKM Partners upped their target price on Chubb from $150.00 to $180.00 in a research report on Friday, November 27th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. Chubb presently has an average rating of "Buy" and a consensus target price of $153.95. Read more …

Week's Most Significant Insider Trades: Week of October 26, 2020

 

Disposals:

 

General Mills, Inc. (NYSE:GIS) insider Shawn P. Ogrady sold 6,310 shares of General Mills stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $60.77, for a total value of $383,458.70. Following the completion of the transaction, the insider now owns 129,257 shares in the company, valued at approximately $7,854,947.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

 Shares of General Mills stock traded down $0.50 during midday trading on Monday, reaching $61.28. The company had a trading volume of 66,634 shares, compared to its average volume of 4,125,454. The stock has a fifty day moving average price of $60.65 and a 200 day moving average price of $61.47. The company has a debt-to-equity ratio of 1.24, a current ratio of 0.70 and a quick ratio of 0.49. The firm has a market cap of $37.77 billion, a PE ratio of 16.52, a P/E/G ratio of 2.27 and a beta of 0.60. General Mills, Inc. has a fifty-two week low of $46.59 and a fifty-two week high of $66.14.  Read more …

 

Accenture plc (NYSE:ACN) insider Ellyn Shook sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $227.74, for a total value of $1,138,700.00. Following the transaction, the insider now owns 19,391 shares of the company’s stock, valued at approximately $4,416,106.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

NYSE:ACN traded up $3.36 during trading hours on Tuesday, reaching $222.59. The company’s stock had a trading volume of 40,944 shares, compared to its average volume of 1,782,384. The company has a market capitalization of $146.27 billion, a P/E ratio of 28.08, a price-to-earnings-growth ratio of 2.86 and a beta of 1.06. Accenture plc has a 12 month low of $137.15 and a 12 month high of $247.82. The stock has a 50 day moving average price of $229.24 and a two-hundred day moving average price of $212.84. Read more …

 

UnitedHealth Group Incorporated (NYSE:UNH) Director Stephen J. Hemsley sold 98,579 shares of the firm's stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $329.47, for a total transaction of $32,478,823.13. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Shares of NYSE:UNH traded down $2.55 during trading on Tuesday, reaching $320.51. 2,426,439 shares of the company traded hands, compared to its average volume of 4,187,595. The firm has a fifty day simple moving average of $314.09 and a 200 day simple moving average of $302.05. The firm has a market cap of $307.02 billion, a P/E ratio of 18.49, a price-to-earnings-growth ratio of 1.53 and a beta of 0.68. UnitedHealth Group Incorporated has a 1-year low of $187.72 and a 1-year high of $335.65. The company has a quick ratio of 0.84, a current ratio of 0.82 and a debt-to-equity ratio of 0.59. Read more …

 

 

BlackRock, Inc. (NYSE:BLK) Director Mark Wiedman sold 3,850 shares of BlackRock stock in a transaction on Monday, October 26th. The shares were sold at an average price of $626.47, for a total transaction of $2,411,909.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Mark Wiedman also recently made the following trade(s):

On Thursday, August 6th, Mark Wiedman sold 360 shares of BlackRock stock. The shares were sold at an average price of $583.20, for a total transaction of $209,952.00.

Shares of BLK stock traded down $13.82 during midday trading on Wednesday, hitting $600.71. 641,802 shares of the company were exchanged, compared to its average volume of 950,465. The firm has a market capitalization of $91.60 billion, a P/E ratio of 19.92, a PEG ratio of 2.20 and a beta of 1.23. The company has a debt-to-equity ratio of 0.66, a quick ratio of 4.02 and a current ratio of 4.02. The firm’s 50 day moving average price is $586.70 and its two-hundred day moving average price is $553.24. BlackRock, Inc. has a 52 week low of $323.98 and a 52 week high of $666.64. Read more …

 

Week's Most Significant Insider Trades: Week of July 22, 2019

Acquisitions:

Bank of New York Mellon Corp (NYSE:BK) Vice Chairman William M. Daley bought 11,350 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were bought at an average price of $44.93 per share, for a total transaction of $509,955.50. Following the completion of the acquisition, the insider now owns 5,700 shares of the company’s stock, valued at $256,101. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

BK stock traded up $0.55 during trading on Monday, hitting $45.82. The company had a trading volume of 4,900,280 shares, compared to its average volume of 5,011,035. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.68 and a current ratio of 0.71. The company has a 50-day simple moving average of $43.86. Bank of New York Mellon Corp has a 12 month low of $42.13 and a 12 month high of $54.47. The company has a market cap of $43.35 billion, a PE ratio of 10.88, a price-to-earnings-growth ratio of 1.39 and a beta of 1.04. Read more …

CROWN CASTLE IN/SH SH (NYSE:CCI) Director J Landis Martin purchased 16,300 shares of the firm’s stock in a transaction on Tuesday, July 23rd. The stock was bought at an average price of $127.33 per share, with a total value of $2,075,479.00. Following the acquisition, the director now owns 130,617 shares in the company, valued at $16,631,462.61. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of CCI opened at $130.58 on Friday. The firm has a 50 day simple moving average of $132.66. CROWN CASTLE IN/SH SH has a 52-week low of $103.21 and a 52-week high of $137.85. The firm has a market cap of $53.83 billion, a price-to-earnings ratio of 23.83, a price-to-earnings-growth ratio of 1.48 and a beta of 0.33. The company has a debt-to-equity ratio of 1.99, a quick ratio of 0.76 and a current ratio of 0.76. Read more …

Air Products & Chemicals, Inc. (NYSE:APD) CEO Seifi Ghasemi acquired 20,000 shares of Air Products & Chemicals stock in a transaction dated Friday, July 26th. The shares were purchased at an average price of $227.16 per share, with a total value of $4,543,200.00. Following the acquisition, the chief executive officer now owns 453,783 shares of the company’s stock, valued at $103,081,346.28. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of APD stock opened at $230.55 on Friday. The company has a current ratio of 2.28, a quick ratio of 2.16 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $50.11 billion, a PE ratio of 30.95, a P/E/G ratio of 2.26 and a beta of 0.83. The company has a 50 day moving average of $224.80. Air Products & Chemicals, Inc. has a 1 year low of $148.44 and a 1 year high of $231.45. Read more …